MedPath

Ascent Pharmaceuticals Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

22

FDA:22

Drug Approvals

LISDEXAMFETAMINE DIMESYLATE

Approval Date
Aug 25, 2023
FDA

LISDEXAMFETAMINE DIMESYLATE

Approval Date
Aug 25, 2023
FDA

PALIPERIDONE

Approval Date
Aug 23, 2023
FDA

MELOXICAM

Approval Date
Jun 8, 2023
FDA

IBUPROFEN AND FAMOTIDINE

Approval Date
Mar 15, 2023
FDA

LEVOTHYROXINE SODIUM

Approval Date
Jan 19, 2023
FDA

DEXMETHYLPHENIDATE HYDROCHLORIDE

Approval Date
Dec 10, 2021
FDA

FAMOTIDINE

Approval Date
Oct 22, 2021
FDA

GABAPENTIN

Approval Date
Oct 5, 2021
FDA

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Approval Date
Sep 30, 2021
FDA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.